POPS RICHARD F

Director at NEUROCRINE BIOSCIENCES INC · on record since Jun 30, 2006
Director at ALKERMES INC · on record since Jun 20, 2006
Director at EPIRUS Biopharmaceuticals, Inc. · on record since Jun 5, 2006
Director at Sirtris Pharmaceuticals, Inc. · on record since May 22, 2007
Chief Executive Officer at ALKERMES INC · on record since Oct 21, 2003
Director at Epizyme, Inc. · on record since May 30, 2013
Director at ACCELERON PHARMA INC · on record since Sep 18, 2013

Insider trading activity of POPS RICHARD F

Transactions on record: 771; since Oct 21, 2003

Open-market buys: 0

Open-market sells: 170; $150M

Companies traded: 6; last filing May 29, 2026

Figures computed from official regulatory filings — .

Companies where POPS RICHARD F has traded

NEUROCRINE BIOSCIENCES INC112 tx · $20.4M · May 29, 2026
Alkermes plc.471 tx · $206.3M · Mar 4, 2026
Epizyme, Inc.8 tx · Jun 2, 2020
ACCELERON PHARMA INC14 tx · $1.7M · Jan 29, 2019
ALKERMES INC162 tx · $10.8M · Sep 20, 2011
EPIRUS Biopharmaceuticals, Inc.4 tx · Jun 2, 2008

Track record of POPS RICHARD F

Insufficient history for a statistical track record (fewer than 5 open-market buys).

Transaction history of POPS RICHARD F

Co-insiders of POPS RICHARD F

This page republishes public regulatory disclosures.

Company	Filed	Type	Qty	Price	Value · USD	Signals	Src
NEUROCRINE BIOSCIENCES INCListing on record	May 29, 2026	AwardD (derivative)	2,567	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
NEUROCRINE BIOSCIENCES INCListing on record	May 21, 2026	ExerciseD (derivative)	-3,318	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
NEUROCRINE BIOSCIENCES INCListing on record	May 21, 2026	Exercise	3,318	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
NEUROCRINE BIOSCIENCES INCListing on record	May 18, 2026	Exercise	15,000	47.89 USD	$718.4K		SEC
NEUROCRINE BIOSCIENCES INCListing on record	May 18, 2026	ExerciseD (derivative)	-15,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
NEUROCRINE BIOSCIENCES INCListing on record	May 18, 2026	Sell	-15,000	157.65 USD	$2.4M		SEC
Alkermes plc.Listing on record	Mar 4, 2026	AwardD (derivative)	88,843	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Alkermes plc.Listing on record	Feb 6, 2026	Other	-62,230	33.55 USD	$2.1M	Unusual size	SEC
Alkermes plc.Listing on record	Feb 6, 2026	Award	149,580	—	n/a (No price was disclosed in the filing)		SEC
NEUROCRINE BIOSCIENCES INCListing on record	May 22, 2025	AwardD (derivative)	3,318	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
NEUROCRINE BIOSCIENCES INCListing on record	May 22, 2025	ExerciseD (derivative)	-2,869	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
NEUROCRINE BIOSCIENCES INCListing on record	May 22, 2025	Exercise	2,869	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Alkermes plc.Listing on record	Feb 20, 2025	AwardD (derivative)	293,921	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Alkermes plc.Listing on record	Feb 7, 2025	Award	190,640	—	n/a (No price was disclosed in the filing)		SEC
Alkermes plc.Listing on record	Feb 7, 2025	Other	-79,925	31.39 USD	$2.5M	Unusual size	SEC
NEUROCRINE BIOSCIENCES INCListing on record	May 23, 2024	AwardD (derivative)	2,869	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
NEUROCRINE BIOSCIENCES INCListing on record	May 21, 2024	Exercise	4,199	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
NEUROCRINE BIOSCIENCES INCListing on record	May 21, 2024	ExerciseD (derivative)	-4,199	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
NEUROCRINE BIOSCIENCES INCListing on record	May 21, 2024	Sell	-2,100	141.84 USD	$297.9K		SEC
NEUROCRINE BIOSCIENCES INCListing on record	Mar 15, 2024	ExerciseD (derivative)	-23,200	42.76 USD	$992K		SEC
NEUROCRINE BIOSCIENCES INCListing on record	Mar 15, 2024	Exercise	23,200	42.76 USD	$992K		SEC
NEUROCRINE BIOSCIENCES INCListing on record	Mar 15, 2024	Sell	-23,200	140.33 USD	$3.3M		SEC
NEUROCRINE BIOSCIENCES INCListing on record	Mar 12, 2024	Sell	-1,700	140.05 USD	$238.1K		SEC
NEUROCRINE BIOSCIENCES INCListing on record	Mar 12, 2024	ExerciseD (derivative)	-100	42.76 USD	$4.3K		SEC
NEUROCRINE BIOSCIENCES INCListing on record	Mar 12, 2024	ExerciseD (derivative)	-1,700	42.76 USD	$72.7K		SEC

Company	Filed	Type	Qty	Price	Value · USD	Signals	Src
NEUROCRINE BIOSCIENCES INCListing on record	May 29, 2026	AwardD (derivative)	2,567	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
NEUROCRINE BIOSCIENCES INCListing on record	May 21, 2026	ExerciseD (derivative)	-3,318	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
NEUROCRINE BIOSCIENCES INCListing on record	May 21, 2026	Exercise	3,318	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
NEUROCRINE BIOSCIENCES INCListing on record	May 18, 2026	Exercise	15,000	47.89 USD	$718.4K		SEC
NEUROCRINE BIOSCIENCES INCListing on record	May 18, 2026	ExerciseD (derivative)	-15,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
NEUROCRINE BIOSCIENCES INCListing on record	May 18, 2026	Sell	-15,000	157.65 USD	$2.4M		SEC
Alkermes plc.Listing on record	Mar 4, 2026	AwardD (derivative)	88,843	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Alkermes plc.Listing on record	Feb 6, 2026	Other	-62,230	33.55 USD	$2.1M	Unusual size	SEC
Alkermes plc.Listing on record	Feb 6, 2026	Award	149,580	—	n/a (No price was disclosed in the filing)		SEC
NEUROCRINE BIOSCIENCES INCListing on record	May 22, 2025	AwardD (derivative)	3,318	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
NEUROCRINE BIOSCIENCES INCListing on record	May 22, 2025	ExerciseD (derivative)	-2,869	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
NEUROCRINE BIOSCIENCES INCListing on record	May 22, 2025	Exercise	2,869	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Alkermes plc.Listing on record	Feb 20, 2025	AwardD (derivative)	293,921	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Alkermes plc.Listing on record	Feb 7, 2025	Award	190,640	—	n/a (No price was disclosed in the filing)		SEC
Alkermes plc.Listing on record	Feb 7, 2025	Other	-79,925	31.39 USD	$2.5M	Unusual size	SEC
NEUROCRINE BIOSCIENCES INCListing on record	May 23, 2024	AwardD (derivative)	2,869	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
NEUROCRINE BIOSCIENCES INCListing on record	May 21, 2024	Exercise	4,199	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
NEUROCRINE BIOSCIENCES INCListing on record	May 21, 2024	ExerciseD (derivative)	-4,199	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
NEUROCRINE BIOSCIENCES INCListing on record	May 21, 2024	Sell	-2,100	141.84 USD	$297.9K		SEC
NEUROCRINE BIOSCIENCES INCListing on record	Mar 15, 2024	ExerciseD (derivative)	-23,200	42.76 USD	$992K		SEC
NEUROCRINE BIOSCIENCES INCListing on record	Mar 15, 2024	Exercise	23,200	42.76 USD	$992K		SEC
NEUROCRINE BIOSCIENCES INCListing on record	Mar 15, 2024	Sell	-23,200	140.33 USD	$3.3M		SEC
NEUROCRINE BIOSCIENCES INCListing on record	Mar 12, 2024	Sell	-1,700	140.05 USD	$238.1K		SEC
NEUROCRINE BIOSCIENCES INCListing on record	Mar 12, 2024	ExerciseD (derivative)	-100	42.76 USD	$4.3K		SEC
NEUROCRINE BIOSCIENCES INCListing on record	Mar 12, 2024	ExerciseD (derivative)	-1,700	42.76 USD	$72.7K		SEC